Background. Rapid molecular tests combined with Antimicrobial Stewardship Program (ASP) interventions have provided opportunities to optimize patient outcomes and reduce unnecessary antimicrobial use. Our institution currently uses an FDA approved influenza/respiratory syncytial virus polymerase chain reaction (PCR) assay and multiplex respiratory panel. In addition, our institution commonly utilizes procalcitonin (PCT) levels. The ASP at Summa Health System -Akron Campus (SHS-AC) routinely recommends use of these rapid diagnostic tests to assist with antimicrobial and antiviral usage, including the discontinuation of antibiotics in influenza positive patients in the absence of a concurrent bacterial infection.
Methods. A retrospective review of all ASP interventions on influenza positive patients at SHS-AC was performed from December 2017 to March 2018. The ASP reviewed all patients on broad-spectrum antibiotics >48 hours and all influenza positive patients without Infectious Disease consultation. The appropriateness of antimicrobial and antiviral therapy was assessed, including assessment of culture and PCR results, PCT levels, indication of therapy, and renal function. For patients with a positive influenza PCR and low PCT without evidence of bacterial infection, the recommendation was to discontinue antibacterial use. Data collected included: intervention type, acceptance rate, PCT levels, and influenza subtype.
Results. Two hundred thirty-three total recommendations were made by the ASP on influenza positive patients, with a 96.6% acceptance rate. Interventions included the following: obtain PCT level (54/233), de-escalate Background. Rapid diagnostic testing (RDT) for Gram-positive blood cultures has previously shown to significantly decrease time to appropriate antibiotic therapy as compared with traditional microbiological methods. Implementation of RDT with antimicrobial stewardship team (AST) notification may significantly improve RDT use and decrease time to optimal therapy; however, in community hospitals with limited resources AST notification may not be feasible. This study aimed to determine the impact of RDT implementation without AST notification on time to appropriate antibiotic therapy for blood cultures growing Gram-positive cocci (GPC) in clusters in a community teaching hospital.
Methods. A retrospective quasi-experimental study was conducted evaluating adult inpatients with a blood culture positive for GPC in clusters. The primary outcome of this study was to compare the time to appropriate therapy for Staphylococcal bacteremia in the pre-RDT group (January 1-June 30, 2016) vs. post-RDT group (January 1-June 30, 2017). Secondary endpoints included comparing the number of anti-MRSA doses administered to patients whose cultures grew coagulase-negative staphylococcus (CoNS) determined contaminants and length of stay (LOS) between groups.
Results. Two hundred fifty-two patients were included in the study (pre-RDT n = 143, post-RDT n = 109). There were 58 patients with Staphylococcus aureus bacteremia (SAB) and 194 patients with CoNS. Mean time to active therapy for SAB following Gram-stain result was similar between groups (pre-RDT 4.1 hours vs. post-RDT 1.06 hours, P = 0.157). The median time to discontinuation of antibiotics for CoNS contaminants was significantly decreased in the post-RDT group (26.38 vs. 8.27 hours, P = 0.006) and the median number of anti-MRSA doses was also significantly decreased (1 vs. 0 dose, P = 0.003). In the post-RDT group, significantly fewer patients with CoNS cultures had empiric anti-MRSA therapy ordered after Gram-stain (50% vs. 24.4%, P = 0.042). Mean LOS was significantly shorter for patients with CoNS contaminants in the post-RDT group (10.1 vs. 7.5 days, P = 0.036).
Conclusion. Implementation of the RDT without AST notification significantly improved time to de-escalation, decreased empiric anti-MRSA antibiotic exposure, and resulted in significantly shorter LOS for patients with CoNS contaminated blood cultures.
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